abstract |
(57) Abstract: The present invention provides a method for treating depression, particularly refractory depression, in mammals including humans by administering a sigma receptor ligand in combination with an antidepressant. SOLUTION: The present invention also relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier, a sigma receptor ligand and a serotonin reuptake inhibitor. |